header-logo
GettyImages-609179959-hero
Hematology and Oncology
Fumou Sun, PhD

Fumou Sun, PhD

Assistant Professor

Locations

  • TBRC 4885
    Hematology and Oncology – Medicine
    Discovery & Developmental Therapeutics, Cancer Center

Contact Information

Education

PhD, Microbiological and Biochemical Pharmacy, China Pharmaceutical University, Nanjing, 2019

Biography

Dr. Sun is an Assistant Professor of medicine at the Medical College of Wisconsin, Division of Hematology and Oncology. Dr. Sun’s research interests focus on tumor immunotherapy, particularly the novel Chimeric Antigen Receptor T Cell (CAR-T) and multifunctional antibody therapies.

Dr. Sun earned his PhD from China Pharmaceutical University in 2019 and spent several years conducting advanced research in tumor genetics and immunotherapy at the University of Iowa, the Medical College of Wisconsin (MCW), and the University of Arkansas for Medical Sciences. In 2024, Dr. Sun returned to MCW, where he collaborates closely with clinical colleagues to advance the clinical applications of tumor immunotherapy.

Dr. Sun leads multiple funded projects and holds several patent applications. His research has been published in over 30 high-impact journals, including The Journal of Clinical Investigation (JCI), Nature Communications, and Cancer Research. He has received numerous prestigious awards, such as the 24th Annual ECOG-ACRIN Young Investigator Award, the American Society of Hematology (ASH) Abstract Achievement Awards in 2022 and 2023, the Young Investigator Award at the 17th International Myeloma Workshop (IMW) of the International Myeloma Society, and the Scholar-in-Training Award at the AACR Annual Meeting.

Research Interests

  • Immunotherapy
  • Chimeric Antigen Receptor T Cell Therapy
  • Chimeric Antigen Receptor NK Cell Therapy
  • Multifunctional Antibody Therapy
  • Oncolytic Virus Therapy
  • Hematologic Malignancies
  • Solid Tumors

Dr. Sun is dedicated to research in the field of tumor immunotherapy, particularly focusing on the development and application of novel Chimeric Antigen Receptor T Cell (CAR-T) immunotherapies. His research focuses on enhancing the therapeutic efficacy of CAR-T cells in treating relapsed and refractory tumors, as well as uncovering the molecular mechanisms underlying therapy resistance.

In addition, Dr. Sun is actively developing combinatory strategies involving CAR-T cells and oncolytic viruses to overcome the challenges associated with solid tumor treatment. He is also committed to innovating multifunctional antibody therapies, aiming to broaden the versatility of antibody-based treatments such as antibody-drug conjugates (ADCs) and bispecific antibodies.

Publications

Publications of Fumou Sun PhD from the Faculty Collaboration Database

© 2025 Medical College of Wisconsin.  All rights reserved.  | Terms and Privacy | Web Accessibility Statement

Non-Discrimination Statement
The Medical College of Wisconsin (MCW) is committed to fostering a diverse community of outstanding faculty, staff, and students, as well as ensuring equal educational opportunity, employment, and access to services, programs, and activities, without regard to an individual's race, color, national origin, religion, age, disability, sex, gender identity/expression, sexual orientation, marital status, pregnancy, predisposing genetic characteristic, or military status. Employees, students, applicants or other members of the MCW community (including but not limited to vendors, visitors, and guests) may not be subjected to harassment that is prohibited by law or treated adversely or retaliated against based upon a protected characteristic. MCW’s policy as well as federal and state laws and regulations prohibit unlawful discrimination and harassment.